Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

COTTONE, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.652
EU - Europa 5.870
AS - Asia 4.722
SA - Sud America 677
AF - Africa 161
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 7
Totale 23.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.407
SG - Singapore 1.753
RU - Federazione Russa 1.330
CN - Cina 1.138
IT - Italia 1.018
UA - Ucraina 773
DE - Germania 636
BR - Brasile 509
FI - Finlandia 492
HK - Hong Kong 479
VN - Vietnam 435
GB - Regno Unito 385
PL - Polonia 317
IE - Irlanda 300
FR - Francia 238
JP - Giappone 224
CA - Canada 149
IN - India 136
SE - Svezia 116
KR - Corea 111
BD - Bangladesh 99
NL - Olanda 54
MX - Messico 49
AR - Argentina 46
BE - Belgio 43
IQ - Iraq 42
ES - Italia 40
TR - Turchia 39
CI - Costa d'Avorio 38
PK - Pakistan 38
MY - Malesia 35
ZA - Sudafrica 32
RO - Romania 30
VE - Venezuela 30
UZ - Uzbekistan 26
AU - Australia 25
CO - Colombia 23
EC - Ecuador 22
MA - Marocco 22
ID - Indonesia 20
SA - Arabia Saudita 20
AE - Emirati Arabi Uniti 19
CH - Svizzera 17
EG - Egitto 17
PY - Paraguay 17
CL - Cile 16
AT - Austria 14
PH - Filippine 14
CR - Costa Rica 13
JO - Giordania 12
KE - Kenya 12
RS - Serbia 12
JM - Giamaica 11
IL - Israele 9
NP - Nepal 9
BG - Bulgaria 8
GR - Grecia 8
LB - Libano 8
LT - Lituania 8
TN - Tunisia 8
TW - Taiwan 7
DZ - Algeria 6
GE - Georgia 6
IR - Iran 6
NG - Nigeria 6
PA - Panama 6
SC - Seychelles 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
KG - Kirghizistan 5
PT - Portogallo 5
BY - Bielorussia 4
CZ - Repubblica Ceca 4
EU - Europa 4
KZ - Kazakistan 4
BH - Bahrain 3
ET - Etiopia 3
HU - Ungheria 3
LK - Sri Lanka 3
NO - Norvegia 3
PE - Perù 3
PS - Palestinian Territory 3
QA - Qatar 3
SN - Senegal 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BW - Botswana 2
CM - Camerun 2
DO - Repubblica Dominicana 2
EE - Estonia 2
KH - Cambogia 2
MM - Myanmar 2
PR - Porto Rico 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
Totale 23.096
Salva come PNG Salva come JPEG
Città #
Ashburn 1.320
Singapore 1.213
Fairfield 1.141
Woodbridge 876
San Jose 712
Chandler 657
Houston 635
Wilmington 470
Hong Kong 459
Jacksonville 439
Ann Arbor 438
Seattle 425
Cambridge 387
Dublin 299
Zgierz 274
Moscow 227
Santa Clara 223
Palermo 219
Tokyo 218
Medford 210
Frankfurt am Main 204
Beijing 188
Nanjing 161
Council Bluffs 158
Los Angeles 156
Princeton 139
Ho Chi Minh City 133
Altamura 126
Lauterbourg 120
Hanoi 109
Tulsa 109
Des Moines 104
Dearborn 91
Lawrence 89
New York 86
Dallas 82
Boardman 81
San Diego 73
Hefei 71
Munich 71
Montréal 61
Mcallen 58
Milan 57
Buffalo 55
Shenyang 52
Helsinki 49
Chicago 47
Nanchang 47
Venice 42
Brussels 41
Kumar 41
São Paulo 41
London 40
The Dalles 40
Abidjan 38
Ludwigshafen am Rhein 38
Seongnam 37
Tianjin 37
Omaha 36
Jiaxing 34
Phoenix 34
Atlanta 30
Redwood City 30
Hebei 28
Changsha 27
Saint Petersburg 26
Amsterdam 25
Rome 24
Jinan 23
Auburn Hills 22
Da Nang 22
Guangzhou 21
Montreal 21
Orem 21
San Paolo di Civitate 21
Warsaw 21
Columbus 20
Johannesburg 20
City of London 19
Haiphong 19
Kuala Lumpur 19
Tashkent 19
Verona 19
Chennai 18
Rio de Janeiro 18
Brooklyn 17
Nuremberg 17
San Mateo 17
Shanghai 17
Washington 17
San Francisco 16
Manchester 15
Orange 15
Pune 14
Zhengzhou 14
Denver 13
Philadelphia 13
Quito 13
Falls Church 12
Lanzhou 12
Totale 14.873
Salva come PNG Salva come JPEG
Nome #
NUTRITION, MALNUTRITION AND DIETARY INTERVENTIONS IN INFLAMMATORY BOWEL DISEASE 569
Prurigo nodularis of Hyde treated with low-dose thalidomide. 355
Incidence of Crohn's disease and Card 15 mutation in a small township in Sicily 276
Severe acute colitis associated with CMV:a prevalence study 233
Cyclosporine or infliximab as rescue therapy in severe 2 refractory ulcerative colitis: Early and long-term data 3 from a retrospective observational study 233
Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease 233
An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C 233
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 229
A. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. 228
An Unusual Presentation of Zollinger-Ellison Syndrome 227
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease 227
Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis 224
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. 223
Clinical and endoscopic presentation of primary gastric lymphoma:a multicenter study 217
Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases 217
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease study 216
Infliximab and ulcerative colitis 215
EFFICACY AND SAFETY OF ENDOSCOPIC BALLOON DILATION OF SYMPTOMATIC INTESTINAL CROHN'S DISEASE STRICTURES 215
Postoperative maintenance therapy for inflammatory bowel disease 215
Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial. 211
JC Virus, Helicobacter pylori, and Oesophageal Achalasia: Preliminary Results from a Retrospective Case-Control Study 211
Systematic review: macrophage activation syndrome in inflammatory bowel disease 209
COLORECTAL CANCER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: PRELIMINARY RESULTS FROM AN ONGOING CASE-CONTROL STUDY 207
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 206
The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature. 205
A rare case of ulcerative proctitis associated with type B lymphomatoid papulosis and superimposed human cytomegalovirus infection. 203
Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures. 202
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 201
The frame.shift mutation of the NOD2/Card15 gene is significantly increased in ulcerative colitis: an IG-IBD study 199
Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease. 199
CA-19 to rule out Pancreatic or Biliary Cancer among patients with cholestasis:an unsuitable ? 199
An unusual presentation of T-lymphoma in a Crohn's 4 disease patient treated with combo therapy: We are 5 willing to take a risk of serious adverse events for a 6 doubtful benefit? 196
Complete clinical remission after high dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy 195
Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study 195
MINIMIZING INFLIXIMAB TOXICITY IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE 193
Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis 193
Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease 193
Clinical course of ulcerative colitis 192
Toxic megacolon and human Cytomegalovirus in a series of severe ulcerative colitis patients 192
Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights 191
Radiologia e malattia celiaca dell'adulto 190
CLINICAL COURSE OF SEVERE COLITIS: A COMPARISON BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS. 190
Cancer in Crohn's Disease patients treated with infliximab: A long-term multicenter matched pair study 188
Calprotectin in the prediction of endoscopic post-surgical recurrence in CD 187
THE ROLE OF CARD15 MUTATIONS AND SMOKING IN THE COURSE OF DISEASE IN A MEDITERRANEAN AREA 186
Infliximab in the treatment of Crohn's disease :predictors of response in an Italian multicenter open study 184
Crohn's disease:a comparative prospective study of transabdominal ultrasonography,small intestine contrastultrasonography and small bowel enema 184
Leucocytapheresis in patients with moderate severe steroid dependant Ulcerative Colitis:clinical response without endoscopic response 184
Antibiotic treatment of Crohn's disease:results of a multicentre double blind randomized placebo controlled trial with Rifamixin 183
A real life comparison of the efficacy of adalimumab versus golimumab in moderate-to-severe ulcerative colitis. A multicenter experience from the sicilian network for inflammatory bowel disease (SN-IBD) 182
Methodological problems in RCTs on IBD 179
Long term follow-up in an incident cohort of 583 pts with CD 177
IL-23R determines susceptibility in Crohn's disease in a Mediterranean area 176
Oral valganciclovir for coloni c dilatation in ulcerative colitis associated with Human cytomegalovirus infection 175
Infliximab, azathioprine or combination therapy in the treatment of active Crohn's disease. 174
COULD JC VIRUS PROVOKE METASTASIS IN COLON CANCER? 173
The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound 172
ATG16L1 contribution to Crohn's disease risk in Sicily 170
Cytomegalovirus and Inflammmatory bowel disease:is there a link ? 169
Infliximab prevents Crohn's disease recurrence after ileal resection. 169
Burden of Crohn's disease: economics and quality of life aspects in Italy. 169
Infliximab to treat Crohn's disease: an update 168
Tofacitinib in active ulcerative colitis 168
Cancer in Infliximab-treated or untreated crohn's disease patients:a 2 years longer follow-up from a multicenter matched pair study 167
NEWLY DIAGNOSED NEOPLASIA IN CROHN DISESE PATIENTS TREATED WITH INFLIXIMAB;A 1 YEAR LONGER FOLLOW UP FROM A MULTICENTER MATCHED PAIR STUDY 167
Improving patients Qol:how the success of treatment can improve workability 166
Infliximab in moderate to severe sateroid dipendent or refractory severe ulcerative colitis:short term results of 21 case treated 165
Unusual perforation after balloon dilation in a Crohn's disease patient:report of a case 165
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. 164
Natural history of cytomegalovirus infection in a cohort of patients diagnosed with moderate severe ulcerative colitis 163
Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation. 162
Severe acute colitis associated with citomegalovirus 160
Methodology for high-quality studies on course and prognosis of inflammatory bowel disease. 160
Radiofrequency thermal ablation vs percutaneous ethanol injection for small hcc in cirrhosis:metanalysis of randomized controlled trials 160
Ultrasound in Crohn's disease 159
Appropriateness of immunosupprerssive drugs in inflammatory bowel disease assessed by RAND method :Italian group for IBD position statement 159
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis. 159
VALIDATION OF A MODIFIED MODEL OF TNBS-INDUCED COLITIS IN RATS. HOW TO INDUCE A CHEMICAL COLITIS IN RATS. 157
efficacy and safety of endoscopic ballon dilatation of symptomatic gastrointestinal Crohn's disease strictures 156
Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis? 156
Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit 155
The sicilian network for inflammatory bowel disease (SN-IBD): preliminary data on efficacy of biological therapy. 155
Smoking therapy may be an extreme cure in exsmokers with steroid-dependent and resistant ulcerative colitis. 155
a meta-analysis of the placebo rate of clinical relapse and severe endoscopic recurrence in post-operative maintenance therapy in Crohn's disease 154
Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. 154
randomized clinical trials in perianal disease. 154
Psychopharmacology treatment and psychological interventions in irritable bowel syndromel 153
The role of NOD2/CARD15 mutation and smoking in the course of Crohn's disease in a Mediterranean area 151
Investigational agents for Crohn's disease. 150
Infliximab in the treatment of steroid resistant dependant and fistulating crohn's disease:an analysis of predictors of response in an italian multicenter open study in 573 pts 149
NOD2/CARD15 FREQUENCY IN CROHN'DISEASE IN SICILY:AN EPIDEMIOLOGICAL STUDY 149
Natural history of Cytomegalovirus infection diagnosed with moderate-severe ulcerative colitis 149
Le malattie infiammatorie dell'intestino 146
Early postoperative recurrence of severe crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab. 146
Intestinal permeability and Genetic determinants in patients,first degree relatives,and controls in a High incidence area's of Crohn's disease in Southern Italy 145
Marked impact of IL28B genotype in the natural clearance of hepatitis C virus in patients with haemoglobinopathies. 143
Occul Hepatitis B and infliximab induced HBV reactivation 140
PREVALENCE OF CARD15/NOD2 MUTATIONS IN SICILIAN POPULATION 139
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use. 139
a metaregression analysis of the placebo rates of remission and response in clinical trials of biological therapies in active crohn's disease 137
Totale 18.782
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.472 62 376 21 51 43 54 85 67 162 199 84 268
2022/20231.900 202 365 35 185 242 260 71 172 245 12 91 20
2023/2024781 46 145 39 53 91 150 75 34 2 54 32 60
2024/20252.017 49 101 101 230 88 77 109 147 148 216 252 499
2025/20268.119 416 228 421 589 736 1.149 1.072 873 567 1.544 288 236
2026/2027243 243 0 0 0 0 0 0 0 0 0 0 0
Totale 23.407